Supplementary material The Supplementary Material for this article can be found online at: Glossary -SMA -smooth muscle actin AKI acute kidney injury APS astragalus polysaccharides AS-IV Astragaloside IV BUN blood urea nitrogen cGAS cyclic GMP-AMP synthase CKD chronic kidney diseases CPs combined pellet system ECM extracellular matrix EGCG Epigallocatechin-3-O-gallate NP nanoparticle EMT epithelial-mesenchymal transition EZH2 enhancer of zeste homolog-2 H3K27me3 histone H3 lysine 27 trimethylation HO-1 Heme oxygenase-1 IL-1 interleukin-1 miRs microRNAs MMP7 matrix metalloproteinase7 PAA Poricoic acid A PAI plasminogen activator inhibitor PDGF platelet-derived growth factor RAAS renin-angiotensin-aldosterone system RTECs renal tubular epithelial cells Sal Salidroside SalB Salvianolic acid B SNEDDS self-nanoemulsifying drug delivery system SOD superoxide dismutase STAT6 signal transducer and activator of transcription 6 STING stimulator of interferon genes TAS total astragalus saponin TCM Traditional Chinese Medicine TRA total rhubarb anthraquinone TSP-1 thrombospondin-1 UUO unilateral ureteral obstruction References 1 AhmedyO.El-TanboulyD.Al-MokaddemA.El-SaidY
Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG , Fukami N, Maru D, Rashid A, Ajani JA
The 2024 Multi-State Botulinum Toxin Outbreak In April 2024, the CDC and FDA issued a joint health advisory after identifying at least 22 patients across multiple states who were hospitalized following botulinum toxin injections
y kn np sau khi dng
doi: 10.1210/en.2005-1089 [DOI] [PubMed] [Google Scholar] 122
